Therefore, the potential market size for GLP-1 drugs suggests the broadest possible impacts on private insurance premiums and health system spending
Front Bioeng Biotechnol 7:400 Hosseini Shamili F, Alibolandi M, Rafatpanah H, Abnous K, Mahmoudi M, Kalantari M, Taghdisi SM, Ramezani M (2019) Immunomodulatory properties of MSC-derived exosomes armed with high affinity aptamer toward mylein as a platform for reducing multiple sclerosis clinical score
Several other related factors, including diet and exercise habits, weren't included in the analyzed data
placebo) on epigenetic aging rate, adjusting for prespecified covariates
References IDF Diabetes Atlas
Gastroenterology 119 , 521535 (2000)